Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Chemistry & Biodiversity|November 14, 2024
Discovery of New Immunomodulatory Anticancer Thalidomide Analogs: Design, Synthesis, Biological Evaluation and In Silico StudiesAbdallah E Abdallah, Ibrahim H Eissa, Ahmed B M Mehany, et al.
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|March 6, 2021
Multidisciplinary assessment of patients with ischemic stroke, the structure of a stroke team, and first Egyptian experience in adults undergoing transcatheter PFO closure for PFO-related strokeAmr Mansour, Noha M Gamal, Azza A Elfiky, et al.
Journal of Biomolecular Structure & Dynamics|December 15, 2023
New nicotinamide derivatives as potential anticancer agents targeting VEGFR-2: design, synthesis, in vitro, and in silico studiesReda G Yousef, Ibrahim H Eissa, Hazem Elkady, et al.
Case Reports in Cardiology|August 2, 2018
Carney Complex: A Rare Case of Multicentric Cardiac Myxoma Associated with EndocrinopathyYehia Saleh, Basma Hammad, Abdallah Almaghraby, et al.
Bioorganic Chemistry|March 28, 2026
Design, synthesis, and in silico study of VEGFR-2 and HDAC dual acting quinazoline based molecules for anticancer evaluationAbdallah E Abdallah, Esmail M El-Fakharany, Yousra A El-Maradny, et al.
Food & Function|February 9, 2022
Insights into the neuroprotective effects of Salvia officinalis L. and Salvia microphylla Kunth in the memory impairment rat modelIriny M Ayoub, Mina Y George, Esther T Menze, et al.
Future Medicinal Chemistry|July 4, 2025
Synthesis, antiproliferative evaluation and in silico studies of new quinazoline derivatives as VEGFR-2 inhibitorsAbdelsalam Mohamed Abdelsalam Ouf, Adel A Marzouk, Montaser Sh A Shaykoon, et al.
Bioorganic Chemistry|April 29, 2026
Quinoxaline-based scaffolds as dual VEGFR-2/EGFR kinase inhibitors and apoptotic inducers: Design, synthesis, anticancer evaluation, and in silico studyAlaa Elwan, Samiha A El-Sebaey, Hanan A Al-Ghulikah, et al.
Future Medicinal Chemistry|November 14, 2024
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducersReda G Yousef, Ibrahim H Eissa, Hazem Elkady, et al.
European Journal of Medicinal Chemistry|September 27, 2025
Design, synthesis, anticancer evaluation, biological screening, and computational study of novel 6,7-dimethoxyquinazoline derivatives as VEGFR-2 inhibitors and apoptotic inducersMostafa M A Aref, Abdallah E Abdallah, Mohammed A Dahab, et al.
Pageof 8